A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2001
11/29/2001	DE10025948A1 Wirkstoffkombination Combination of active ingredients
11/29/2001	DE10025946A1 Wirkstoffkombination Combination of active ingredients
11/29/2001	DE10025890A1 Dosierung von transdermalen Arzneimittelsystemen Dose of transdermal drug delivery systems
11/29/2001	DE10025238A1 Verwendung substituierter 1-Amino-5-phenylpentan-3-ol- und/oder 1-Amino-6-phenylhexan-3-ol- Verbindungen als Arzneimittel Use of substituted 1-amino-5-phenylpentane-3-ol and / or 1-amino-6-phenylhexane-3-ol compounds as medicaments
11/29/2001	CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410593A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	CA2410567A1 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	CA2410531A1 Combination therapy for treatment of depression
11/29/2001	CA2410530A1 Method of promoting smoking cessation
11/29/2001	CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	CA2410395A1 Agents and methods for increasing brain chaperonin levels
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2409998A1 Benzodiazepine derivatives as app modulators
11/29/2001	CA2409956A1 Use of ciliary neurotrophic factor
11/29/2001	CA2409830A1 Sulfonamide derivatives
11/29/2001	CA2409829A1 Sulfonamide derivatives
11/29/2001	CA2409768A1 Cyclic amino acid derivatives useful as pharmaceutical agents
11/29/2001	CA2409644A1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2409051A1 Antimigraine combination comprising sapindus and emblica extracts
11/29/2001	CA2408925A1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
11/29/2001	CA2408783A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	CA2408781A1 Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone
11/29/2001	CA2408777A1 Dosage of transdermal delivery systems
11/29/2001	CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408566A1 Role of ldl receptor protein-1 (lrp-1) in alzheimer's disease
11/29/2001	CA2408562A1 Dehydroascorbic acid formulations and uses thereof
11/29/2001	CA2408387A1 A ligand for enhancing oral and cns delivery of biological agents
11/29/2001	CA2408141A1 Neurotransmitter transporters
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2408036A1 Combination of growth hormone secretagogues and antidepressants
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2407764A1 O/w emulsion
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158003A1 Antibodies capable to selectively detect prion PrP Sc isoforms
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157992A1 Dihydro-2,3-Benzodiazepine derivatives
11/28/2001	EP1157989A1 Fluorides of 4-substituted piperidine derivatives
11/28/2001	EP1157682A1 Blister package for topiramate tablets
11/28/2001	EP1157275A1 Novel transduction molecules and methods for using same
11/28/2001	EP1157104A2 Pyk2 binding proteins
11/28/2001	EP1157024A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157020A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, method for producing them and their use as medicaments
11/28/2001	EP1157017A1 N-substituted imide derivatives with serotonergic activity
11/28/2001	EP1157009A1 Dopamine d1 receptor agonist compounds
11/28/2001	EP1157006A2 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
11/28/2001	EP1157005A1 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
11/28/2001	EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP1157000A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/28/2001	EP1156856A2 Uses of fluorinated triazoles for treaing pain and affective or attention disorders
11/28/2001	EP1156855A1 Composition comprising a tramadol material and a selective cox-2 inhibitor drug
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156818A2 Methods and compositions for regulating protein-protein interactions
11/28/2001	EP1156811A2 Copper agonist that binds on the copper binding site of app and/or exerts an inhibiting effect on the release of amyloid a beta peptide
11/28/2001	EP1156798A1 Felbamate derived compounds
11/28/2001	EP1156794A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen
11/28/2001	EP1156717A1 A recombinant polypeptide for use in the manufacture of vaccines against campylobacter induced diarrhea and to reduce colonization
11/28/2001	EP0880350B1 Multiple sclerosis treatment
11/28/2001	EP0850234B1 Novel heterocyclic compounds for the treatment of pain and use thereof
11/28/2001	EP0804469B1 T-cell affecting peptides
11/28/2001	EP0784054B1 1,2,3,4-tetrahydroquinoxalinedione derivatives and use as glutamate receptor antagonists
11/28/2001	EP0783503B1 2,7-substituted octahydro-1h-pyrido[ 1,2-a]pyrazine derivatives
11/28/2001	EP0770068B1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents
11/28/2001	EP0698108B1 Adenoviral vectors of animal origin and use thereof in gene therapy
11/28/2001	EP0677051B1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
11/28/2001	EP0673368B1 Novel nicotinic acid esters
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324400A Method of screening for large offspring syndrome
11/28/2001	CN1324367A Cyclic prosaposin-derived peptides and uses thereof
11/28/2001	CN1324360A Bicyclic nitrogen heterocycles
11/28/2001	CN1324359A Tricyclic carboxamides
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324352A 2-phenylpyran-4-one derivatives
11/28/2001	CN1324351A Method for the preparation of citalopram
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324349A Pyrazine compounds
11/28/2001	CN1324258A Aglyco products and method of use
11/28/2001	CN1324251A Method of stimulating prosaposin receptor activity
11/28/2001	CN1324238A Amelioration of apomorphine adverse effects
11/28/2001	CN1324236A Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use
11/28/2001	CN1323813A New polypeptide-neural syndesis ion channel related protein 11 and polynucleotides for coding same
11/28/2001	CN1323796A Novel cyclobutaneindazol carboxylamine compound, their prepn. method and pharmaceutical compositions
11/28/2001	CN1323794A Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
11/28/2001	CN1323793A Schizonepeta lactone and its extraction process and use
11/28/2001	CN1323590A Headache treating traditional Chinese medicine
11/28/2001	CN1323583A Medicinal use of beta-ecdysterone
11/27/2001	US6323369 As analgesics
11/27/2001	US6323365 For therapy of convulsions and epilepsy, and for the treatment of pain and migraine, bipolar disorder
11/27/2001	US6323242 Treatment of disorders secondary to organic impairments
11/27/2001	US6323240 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
11/27/2001	US6323239 Treatment of addiction to ethanol and addictive-related behavior
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323222 1-aza-2-alkyl-6-aryl-cycloalkane compounds

1 ... 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 ... 1833